Organ Biology
Online ISSN : 2188-0204
Print ISSN : 1340-5152
ISSN-L : 1340-5152
小児肝移植医療における免疫抑制療法
阪本 靖介笠原 群生
著者情報
ジャーナル フリー

2013 年 20 巻 2 号 p. 222-226

詳細
抄録

Recent advances in immunosuppression(IS)have improved the outcomes in pediatric liver transplantation(LT). Particular attention should be paid to several difference between children and adults in IS for LT. Better understanding of the pharmacokinetics of immunosuppressants in children is one of the most important issues, although data on this aspect are still insufficient. Controling alloreactivity by appropriate IS is crucial for the success of pediatric LT. In our series of pediatric living donor LT, younger children suffering from acute liver failure often encountered steroid-resistant rejection after LT. The selection of immunosuppressive agents must be clues to overcome steroid-resistant rejection. Epstein-Barr virus(EBV)is also one of the major topics in pediatric LT. Monitoring of EBV-viral DNA load and lymphocyte surface markers may be effective to control EBV infection after LT. Basic and clinical epoch-making data related to immune tolerance have been reported in pediatric recipients undergoing living donor LT in Kyoto, which may bring significant benefits to pediatric LT in the near future.

著者関連情報
© 2013 日本臓器保存生物医学会
前の記事 次の記事
feedback
Top